Crown Holdings Inc has a consensus price target of $106.68 based on the ratings of 23 analysts. The high is $140 issued by BMO Capital on February 10, 2022. The low is $88 issued by Wells Fargo on July 24, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Citigroup, and Morgan Stanley on July 26, 2024, July 25, 2024, and July 24, 2024, respectively. With an average price target of $99 between RBC Capital, Citigroup, and Morgan Stanley, there's an implied 15.55% upside for Crown Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/26/2024 | Buy Now | 22.55% | RBC Capital | Arun Viswanathan | $96 → $105 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 16.71% | Citigroup | Anthony Pettinari | $94 → $100 | Maintains | Buy | Get Alert |
07/24/2024 | Buy Now | 7.38% | Morgan Stanley | Pamela Kaufman | $89 → $92 | Maintains | Equal-Weight | Get Alert |
07/24/2024 | Buy Now | 16.71% | Barclays | Michael Leithead | $95 → $100 | Maintains | Overweight | Get Alert |
07/24/2024 | Buy Now | 19.05% | B of A Securities | George Staphos | $98 → $102 | Maintains | Buy | Get Alert |
07/24/2024 | Buy Now | 2.71% | Wells Fargo | Gabe Hajde | $85 → $88 | Maintains | Equal-Weight | Get Alert |
07/24/2024 | Buy Now | 40.06% | Loop Capital | Alton Stump | $106 → $120 | Maintains | Buy | Get Alert |
07/24/2024 | Buy Now | 10.88% | Truist Securities | Michael Roxland | $88 → $95 | Maintains | Hold | Get Alert |
07/17/2024 | Buy Now | 6.21% | UBS | Cleveland Rueckert | $112 → $91 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | -0.79% | Wells Fargo | Gabe Hajde | $84 → $85 | Maintains | Equal-Weight | Get Alert |
07/08/2024 | Buy Now | 9.71% | Citigroup | Anthony Pettinari | $102 → $94 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | 23.72% | Loop Capital | Alton Stump | $101 → $106 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | -1.96% | Wells Fargo | Gabe Hajde | $76 → $84 | Maintains | Equal-Weight | Get Alert |
05/01/2024 | Buy Now | 5.04% | JP Morgan | Jeffrey Zekauskas | $85 → $90 | Maintains | Overweight | Get Alert |
05/01/2024 | Buy Now | 16.71% | Baird | Ghansham Panjabi | $90 → $100 | Maintains | Outperform | Get Alert |
04/16/2024 | Buy Now | 5.04% | Baird | Ghansham Panjabi | $85 → $90 | Upgrade | Neutral → Outperform | Get Alert |
04/11/2024 | Buy Now | -11.3% | Wells Fargo | Gabe Hajde | $78 → $76 | Maintains | Equal-Weight | Get Alert |
03/27/2024 | Buy Now | 2.71% | Truist Securities | Michael Roxland | $100 → $88 | Downgrade | Buy → Hold | Get Alert |
03/18/2024 | Buy Now | 1.54% | Morgan Stanley | Pamela Kaufman | → $87 | Initiates | → Equal-Weight | Get Alert |
03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Outperform | Get Alert |
02/08/2024 | Buy Now | 13.21% | RBC Capital | Arun Viswanathan | $110 → $97 | Maintains | Outperform | Get Alert |
02/07/2024 | Buy Now | 16.71% | Truist Securities | Michael Roxland | $117 → $100 | Maintains | Buy | Get Alert |
02/07/2024 | Buy Now | -8.96% | Wells Fargo | Gabe Hajde | $93 → $78 | Maintains | Equal-Weight | Get Alert |
02/07/2024 | Buy Now | -0.79% | JP Morgan | Jeffrey Zekauskas | → $85 | Upgrade | Neutral → Overweight | Get Alert |
02/06/2024 | Buy Now | 12.04% | Mizuho | John Roberts | $105 → $96 | Maintains | Buy | Get Alert |
02/06/2024 | Buy Now | 5.04% | Baird | Ghansham Panjabi | → $90 | Reiterates | Neutral → Neutral | Get Alert |
01/16/2024 | Buy Now | 30.72% | UBS | Cleveland Rueckert | → $112 | Initiates | → Buy | Get Alert |
01/04/2024 | Buy Now | 36.55% | Truist Securities | Michael Roxland | $106 → $117 | Maintains | Buy | Get Alert |
12/28/2023 | Buy Now | 22.55% | Mizuho | John Roberts | $96 → $105 | Maintains | Buy | Get Alert |
11/21/2023 | Buy Now | 23.72% | Truist Securities | Michael Roxland | → $106 | Reiterates | Buy → Buy | Get Alert |
10/26/2023 | Buy Now | 28.38% | RBC Capital | Arun Viswanathan | $115 → $110 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | 16.71% | Barclays | Michael Leithead | $110 → $100 | Maintains | Overweight | Get Alert |
10/25/2023 | Buy Now | 22.55% | Citigroup | Anthony Pettinari | $103 → $105 | Maintains | Buy | Get Alert |
10/19/2023 | Buy Now | -13.63% | Wells Fargo | Gabe Hajde | $86 → $74 | Maintains | Equal-Weight | Get Alert |
10/18/2023 | Buy Now | 42.39% | Jefferies | Philip Ng | $123 → $122 | Maintains | Buy | Get Alert |
10/13/2023 | Buy Now | 20.21% | Citigroup | Anthony Pettinari | $106 → $103 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 8.54% | JP Morgan | Jeffrey Zekauskas | $88 → $93 | Maintains | Neutral | Get Alert |
07/27/2023 | Buy Now | 34.22% | RBC Capital | Arun Viswanathan | $97 → $115 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | 17.88% | Goldman Sachs | Adam Samuelson | $91 → $101 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | 49.39% | Loop Capital | Alton Stump | $112 → $128 | Maintains | Buy | Get Alert |
07/26/2023 | Buy Now | 33.05% | Citigroup | Anthony Pettinari | $102 → $114 | Maintains | Buy | Get Alert |
07/26/2023 | Buy Now | 17.88% | Goldman Sachs | Adam Samuelson | $91 → $101 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | 0.37% | Wells Fargo | Gabe Hajde | $80 → $86 | Maintains | Equal-Weight | Get Alert |
07/26/2023 | Buy Now | 28.38% | Barclays | Michael Leithead | $95 → $110 | Maintains | Overweight | Get Alert |
07/11/2023 | Buy Now | 19.05% | Citigroup | Anthony Pettinari | $104 → $102 | Maintains | Buy | Get Alert |
06/27/2023 | Buy Now | 26.05% | Mizuho | Christopher Parkinson | → $108 | Reiterates | Buy → Buy | Get Alert |
04/28/2023 | Buy Now | 13.21% | RBC Capital | Arun Viswanathan | $95 → $97 | Maintains | Outperform | Get Alert |
04/27/2023 | Buy Now | 21.38% | Citigroup | Anthony Pettinari | $103 → $104 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | -6.63% | Wells Fargo | Gabe Hajde | $79 → $80 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | 26.05% | Mizuho | Christopher Parkinson | $103 → $108 | Maintains | Buy | Get Alert |
03/27/2023 | Buy Now | -7.8% | Wells Fargo | Gabe Hajde | $86 → $79 | Maintains | Equal-Weight | Get Alert |
02/13/2023 | Buy Now | 10.88% | Barclays | Michael Leithead | $90 → $95 | Maintains | Overweight | Get Alert |
02/10/2023 | Buy Now | 21.38% | Citigroup | Anthony Pettinari | $97 → $104 | Maintains | Buy | Get Alert |
02/10/2023 | Buy Now | 13.21% | RBC Capital | Arun Viswanathan | $96 → $97 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 20.21% | Mizuho | Christopher Parkinson | $100 → $103 | Maintains | Buy | Get Alert |
02/09/2023 | Buy Now | 0.37% | Wells Fargo | Gabe Hajde | $80 → $86 | Maintains | Equal-Weight | Get Alert |
02/08/2023 | Buy Now | 16.71% | Mizuho | Christopher Parkinson | → $100 | Maintains | Buy | Get Alert |
01/12/2023 | Buy Now | 16.71% | Mizuho | Christopher Parkinson | $96 → $100 | Maintains | Buy | Get Alert |
01/10/2023 | Buy Now | 22.55% | Morgan Stanley | Angel Castillo | $110 → $105 | Maintains | Overweight | Get Alert |
01/09/2023 | Buy Now | -6.63% | Wells Fargo | Gabe Hajde | $76 → $80 | Maintains | Equal-Weight | Get Alert |
01/04/2023 | Buy Now | -6.63% | Baird | Ghansham Panjabi | → $80 | Downgrade | Outperform → Neutral | Get Alert |
12/15/2022 | Buy Now | 5.04% | UBS | Cleveland Rueckert | $105 → $90 | Maintains | Neutral | Get Alert |
10/28/2022 | Buy Now | 5.04% | Barclays | Michael Leithead | $115 → $90 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -5.46% | RBC Capital | Arun Viswanathan | $110 → $81 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | -6.63% | Baird | Ghansham Panjabi | $130 → $80 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | 28.38% | Morgan Stanley | Angel Castillo | $120 → $110 | Maintains | Overweight | Get Alert |
10/26/2022 | Buy Now | 12.04% | Mizuho | Christopher Parkinson | $112 → $96 | Maintains | Buy | Get Alert |
10/26/2022 | Buy Now | 0.37% | Goldman Sachs | Adam Samuelson | $100 → $86 | Maintains | Neutral | Get Alert |
10/26/2022 | Buy Now | -11.3% | Wells Fargo | Gabe Hajde | $92 → $76 | Maintains | Equal-Weight | Get Alert |
10/26/2022 | Buy Now | 22.55% | Credit Suisse | Curt Woodworth | $128 → $105 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | -17.13% | JP Morgan | Jeffrey Zekauskas | $115 → $71 | Downgrade | Overweight → Neutral | Get Alert |
10/24/2022 | Buy Now | 27.22% | Deutsche Bank | Kyle White | $115 → $109 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | 30.72% | Mizuho | Christopher Parkinson | $124 → $112 | Maintains | Buy | Get Alert |
10/12/2022 | Buy Now | 7.38% | Wells Fargo | Gabe Hajde | $100 → $92 | Maintains | Equal-Weight | Get Alert |
10/11/2022 | Buy Now | 13.21% | Citigroup | Anthony Pettinari | $116 → $97 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | 40.06% | Morgan Stanley | Angel Castillo | $130 → $120 | Maintains | Overweight | Get Alert |
10/03/2022 | Buy Now | 34.22% | Barclays | Michael Leithead | $130 → $115 | Maintains | Overweight | Get Alert |
09/15/2022 | Buy Now | 22.55% | UBS | Cleve Rueckert | → $105 | Initiates | → Neutral | Get Alert |
09/07/2022 | Buy Now | 42.39% | RBC Capital | Arun Viswanathan | $120 → $122 | Maintains | Outperform | Get Alert |
07/26/2022 | Buy Now | 51.73% | Morgan Stanley | Angel Castillo | $135 → $130 | Maintains | Overweight | Get Alert |
07/22/2022 | Buy Now | 44.72% | Mizuho | Christopher Parkinson | $126 → $124 | Maintains | Buy | Get Alert |
07/22/2022 | Buy Now | 51.73% | Truist Securities | Michael Roxland | $147 → $130 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | 16.71% | Wells Fargo | Gabe Hajde | $110 → $100 | Maintains | Equal-Weight | Get Alert |
06/09/2022 | Buy Now | 28.38% | Wells Fargo | Gabe Hajde | $150 → $110 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/28/2022 | Buy Now | 66.9% | RBC Capital | Arun Viswanathan | $140 → $143 | Maintains | Outperform | Get Alert |
04/27/2022 | Buy Now | 64.57% | B of A Securities | George Staphos | $139 → $141 | Maintains | Buy | Get Alert |
04/27/2022 | Buy Now | 47.06% | Mizuho | Christopher Parkinson | $131 → $126 | Maintains | Buy | Get Alert |
04/27/2022 | Buy Now | 75.07% | Wells Fargo | Gabe Hajde | $152 → $150 | Maintains | Overweight | Get Alert |
04/13/2022 | Buy Now | 77.4% | Wells Fargo | Gabe Hajde | $132 → $152 | Maintains | Overweight | Get Alert |
02/10/2022 | Buy Now | 63.4% | BMO Capital | Mark Wilde | $110 → $140 | Upgrade | Market Perform → Outperform | Get Alert |
01/20/2022 | Buy Now | 57.56% | Morgan Stanley | Neel Kumar | $129 → $135 | Maintains | Overweight | Get Alert |
10/13/2021 | Buy Now | 50.56% | Mizuho | Christopher Parkinson | — | Initiates | → Buy | Get Alert |
10/06/2021 | Buy Now | 92.58% | Loop Capital | Alton Stump | — | Initiates | → Buy | Get Alert |
09/14/2021 | Buy Now | 61.06% | Truist Securities | — | — | Initiates | → Buy | Get Alert |
The latest price target for Crown Holdings (NYSE:CCK) was reported by RBC Capital on July 26, 2024. The analyst firm set a price target for $105.00 expecting CCK to rise to within 12 months (a possible 22.55% upside). 37 analyst firms have reported ratings in the last year.
The latest analyst rating for Crown Holdings (NYSE:CCK) was provided by RBC Capital, and Crown Holdings maintained their outperform rating.
The last upgrade for Crown Holdings Inc happened on April 16, 2024 when Baird raised their price target to $90. Baird previously had a neutral for Crown Holdings Inc.
The last downgrade for Crown Holdings Inc happened on March 27, 2024 when Truist Securities changed their price target from $100 to $88 for Crown Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crown Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crown Holdings was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
While ratings are subjective and will change, the latest Crown Holdings (CCK) rating was a maintained with a price target of $96.00 to $105.00. The current price Crown Holdings (CCK) is trading at is $85.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.